Biological Products Industry Alliance

Source and Resolution Links

Finish the Investigation Outside Our Dataset

When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.

Workflow Engine

Queries We Should Resolve, Not Just Answer

Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.

Search Intent Cockpit

Biological Products Industry Alliance Form 990, Revenue, CEO Pay, and IRS Filing Signals

Biological Products Industry Alliance is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Biological Products Industry Alliance in one place.

Is Biological Products Industry Alliance Legit?

Some Concerns

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

IRS 990 Data Cockpit

Where the Money Comes From and Where It Goes

Across stored filings, Biological Products Industry Alliance shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.

Decision Cockpit

One-Stop Donor, Research, and Peer Context Hub

Donation Decision Flow

From Trust Check to Better Alternatives

Alternative Shopping

Similar Nonprofits Donors Should Compare

Browse the full Community Improvement peer market in Virginia →

Next Best Actions

Keep the Investigation Moving

Research Workflow

Turn this Form 990 profile into a donor-ready report

Request a concise report for Biological Products Industry Alliance with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.

Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.

Biological Products Industry Alliance directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Biological Products Industry Alliance

Biological Products Industry Alliance (EIN: 200130227) is a nonprofit organization based in Oakton, VA, classified under NTEE code S41. The organization reported total revenue of $1.1M and total assets of $2.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Biological Products Industry Alliance's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

Biological Products Industry Alliance is a mid-size nonprofit that has been operating for 23 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 17.5%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Financial Health Grade: A

In 2023, Biological Products Industry Alliance reported a surplus of $295K with revenue exceeding expenses, holds 40.4 months of operating reserves (strong position), has a debt-to-asset ratio of 7.1% (very low leverage).

Financial Trends

Over 13 years of filings (2011–2023), Biological Products Industry Alliance's revenue has grown at a compound annual growth rate (CAGR) of 17.5%.

IRS Tax-Exempt Classification

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Biological Products Industry Alliance with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

• admin: 7%
• programs: 90%
• fundraising: 3%

According to IRS 990 filings, Biological Products Industry Alliance allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

• The organization reported a surplus of $295K, with revenue exceeding expenses.
• Debt-to-asset ratio: 7.1%.

Executive Compensation Analysis

The Biological Products Industry Alliance consistently reports 0% officer compensation across all available filings, suggesting that executive leadership is either volunteer-based or compensated through mechanisms not classified as direct officer compensation on the 990 form. This indicates a highly efficient use of funds regarding top-level salaries.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Biological Products Industry Alliance's IRS 990 filings:

• Lack of detailed program vs. administrative expense breakdown in provided data, making precise efficiency calculation difficult without full 990 forms.

Strengths

The following positive indicators were identified for Biological Products Industry Alliance:

• Consistent and significant revenue growth over the past decade (from $246,778 in 2014 to $882,035 in 2023).
• Strong asset accumulation, indicating financial stability and capacity (assets grew from $155,801 in 2014 to $1,973,202 in 2023).
• No reported officer compensation across all filings, suggesting efficient use of funds at the executive level.
• Healthy surplus generation, with expenses consistently lower than revenue.
• Consistent IRS 990 filing history, indicating good transparency.

Frequently Asked Questions about Biological Products Industry Alliance

Filing History

IRS 990 filing history for Biological Products Industry Alliance showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Biological Products Industry Alliance's revenue has grown by 591%, moving from $128K to $882K. Total assets increased by 1425.1% over the same period, from $129K to $2.0M. Total functional expenses rose by 495.7%, from $98K to $587K. In its most recent filing year (2023), Biological Products Industry Alliance reported a surplus of $295K, with revenue exceeding expenses. The organization holds $140K in liabilities against $2.0M in assets (debt-to-asset ratio: 7.1%), resulting in net assets of $1.8M.

Year-by-Year Financial Summary

• 2023: Revenue of $882K, expenses of $587K, and assets of $2.0M (revenue +16.2% year-over-year).
• 2022: Revenue of $759K, expenses of $512K, and assets of $1.6M (revenue +34.8% year-over-year).
• 2021: Revenue of $563K, expenses of $368K, and assets of $1.4M (revenue -3.0% year-over-year).
• 2020: Revenue of $581K, expenses of $403K, and assets of $1.2M (revenue -10.1% year-over-year).
• 2019: Revenue of $646K, expenses of $502K, and assets of $954K (revenue -9.8% year-over-year).
• 2018: Revenue of $717K, expenses of $477K, and assets of $1.0M (revenue +10.7% year-over-year).
• 2017: Revenue of $647K, expenses of $490K, and assets of $775K (revenue +14.0% year-over-year).
• 2016: Revenue of $568K, expenses of $428K, and assets of $548K (revenue +37.7% year-over-year).
• 2015: Revenue of $413K, expenses of $297K, and assets of $390K (revenue +67.2% year-over-year).
• 2014: Revenue of $247K, expenses of $241K, and assets of $156K (revenue +23.4% year-over-year).
• 2013: Revenue of $200K, expenses of $207K, and assets of $107K (revenue +15.7% year-over-year).
• 2012: Revenue of $173K, expenses of $165K, and assets of $130K (revenue +35.4% year-over-year).
• 2011: Revenue of $128K, expenses of $98K, and assets of $129K.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for Biological Products Industry Alliance:

Data Sources and Methodology

This transparency report for Biological Products Industry Alliance is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.